Acumen Pharmaceuticals, Inc.

ABOSNASDAQHealthcare● Active

$2.27

+$0.10(+4.52%)

Market Cap$137386529

P/E Ratio—

52W High$3.6

52W Low$1.05

Avg Volume537K

Open$2.20

Beta0.35

Overview

Acumen Pharmaceuticals, Inc.（ABOS）内幕交易

基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。

SEC EDGAR · FMP · ABOS · 截至 2026年6月9日

活动摘要

买入笔数

P-Purchase only

卖出笔数

近12个月

买卖比

0.00

Buy/Sell (by trades)

整体情绪

偏空

↑ Buy 0%仅显示有效交易 · 排除RSU归属100% Sell ↓

Acumen Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale

截至 2026年6月9日

ABOS 季度内部人买卖趋势

ABOS 内幕交易卖出 · ABOS 内幕交易买入 · 季度活动

买入总量（含股权归属）卖出总量

8.4M4.2M0

2024 Q1

2024 Q2

2024 Q4

2025 Q1

2025 Q2

2025 Q4

2026 Q1

2026 Q2

Mobile shows last 4Q · Desktop shows full 8Q

▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度

As of Jun 9, 2026

活跃内部人

近12个月交易最活跃 · ABOS CEO内幕交易

显示全部内部人 · 点击卡片过滤下方交易表

▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API

近期内幕交易记录

ABOS 高管卖出股份 · ABOS 董事内幕交易 · SEC Form 4申报

显示最近 72 条 · 普通股 · 仅Form 4

横向滑动查看全部列

日期	内部人	类型	股数	均价	总金额	交易后持股	申报
Jun 3, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Award	35,500	—	—	48,300	Form 4
Jun 3, 2026	Fountain Nathan B Director	Award	35,500	—	—	54,550	Form 4
Jun 3, 2026	Drapkin Kimberlee C Director	Award	35,500	—	—	48,300	Form 4
Jun 3, 2026	Stalfort John A III Director	Award	35,500	—	—	220,624	Form 4
Jun 3, 2026	Porter Derrell Director	Award	35,500	—	—	48,300	Form 4
Jun 3, 2026	Ives Jeffrey L. Director	Award	35,500	—	—	48,300	Form 4
Jun 3, 2026	Golumbeski George Director	Award	35,500	—	—	35,500	Form 4
Jun 3, 2026	Stoppel Laura Director	Award	35,500	—	—	48,300	Form 4
Mar 16, 2026	RA CAPITAL MANAGEMENT, L.P. Director	Award	6,060,606	$3.30	$20.00M⚡	19,103,785	Form 4
Mar 6, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Option	2,090	$1.85	$4K	176,089	Form 4
Mar 6, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Sale	2,090	$3.26	$7K	173,999	Form 4
Feb 27, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Option	9,406	$1.85	$17K	183,405	Form 4
Feb 27, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Sale	9,406	$3.01	$28K	173,999	Form 4
Jan 26, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Option	15,085	$1.85	$28K	189,084	Form 4
Jan 28, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Option	2,671	$1.85	$5K	176,670	Form 4
Jan 28, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Sale	2,671	$3.00	$8K	173,999	Form 4
Jan 26, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Sale	15,085	$3.00	$45K	173,999	Form 4
Jan 21, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Sale	2,247	$1.81	$4K	180,686	Form 4
Jan 22, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Sale	1,054	$1.84	$2K	179,632	Form 4
Jan 23, 2026	Meisner Derek M Chief Legal Officer & Corp Sec	Sale	5,633	$1.90	$11K	173,999	Form 4
Jan 21, 2026	Siemers Eric Chief Medical Officer	Sale	2,331	$1.80	$4K	256,266	Form 4
Jan 22, 2026	Siemers Eric Chief Medical Officer	Sale	895	$1.82	$2K	255,371	Form 4
Jan 21, 2026	Zuga Matt CFO & Chief Business Officer	Sale	2,473	$1.81	$4K	306,611	Form 4
Jan 22, 2026	Zuga Matt CFO & Chief Business Officer	Sale	1,687	$1.86	$3K	304,924	Form 4
Jan 21, 2026	OConnell Daniel Joseph CEO · Director	Sale	9,346	$1.81	$17K	883,964	Form 4

RA CAPITAL MANAGEMENT, L.P.

Director

Award

日期

Jun 3

股数

35,500

均价

—

总金额

—

View Form 4 on SEC.gov

Fountain Nathan B

Director

Award

日期

Jun 3

股数

35,500

均价

—

总金额

—

View Form 4 on SEC.gov

Drapkin Kimberlee C

Director

Award

日期

Jun 3

股数

35,500

均价

—

总金额

—

View Form 4 on SEC.gov

Stalfort John A III

Director

Award

日期

Jun 3

股数

35,500

均价

—

总金额

—

View Form 4 on SEC.gov

Porter Derrell

Director

Award

日期

Jun 3

股数

35,500

均价

—

总金额

—

View Form 4 on SEC.gov

Ives Jeffrey L.

Director

Award

日期

Jun 3

股数

35,500

均价

—

总金额

—

View Form 4 on SEC.gov

Golumbeski George

Director

Award

日期

Jun 3

股数

35,500

均价

—

总金额

—

View Form 4 on SEC.gov

Stoppel Laura

Director

Award

日期

Jun 3

股数

35,500

均价

—

总金额

—

View Form 4 on SEC.gov

RA CAPITAL MANAGEMENT, L.P.

Director

Award

日期

Mar 16

股数

6,060,606

均价

$3.30

总金额

$20.00M ⚡

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Option

日期

Mar 6

股数

2,090

均价

$1.85

总金额

$4K

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Sale

日期

Mar 6

股数

2,090

均价

$3.26

总金额

$7K

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Option

日期

Feb 27

股数

9,406

均价

$1.85

总金额

$17K

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Sale

日期

Feb 27

股数

9,406

均价

$3.01

总金额

$28K

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Option

日期

Jan 26

股数

15,085

均价

$1.85

总金额

$28K

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Option

日期

Jan 28

股数

2,671

均价

$1.85

总金额

$5K

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Sale

日期

Jan 28

股数

2,671

均价

$3.00

总金额

$8K

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Sale

日期

Jan 26

股数

15,085

均价

$3.00

总金额

$45K

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Sale

日期

Jan 21

股数

2,247

均价

$1.81

总金额

$4K

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Sale

日期

Jan 22

股数

1,054

均价

$1.84

总金额

$2K

View Form 4 on SEC.gov

Meisner Derek M

Chief Legal Officer & Corp Sec

Sale

日期

Jan 23

股数

5,633

均价

$1.90

总金额

$11K

View Form 4 on SEC.gov

Siemers Eric

Chief Medical Officer

Sale

日期

Jan 21

股数

2,331

均价

$1.80

总金额

$4K

View Form 4 on SEC.gov

Siemers Eric

Chief Medical Officer

Sale

日期

Jan 22

股数

895

均价

$1.82

总金额

$2K

View Form 4 on SEC.gov

Zuga Matt

CFO & Chief Business Officer

Sale

日期

Jan 21

股数

2,473

均价

$1.81

总金额

$4K

View Form 4 on SEC.gov

Zuga Matt

CFO & Chief Business Officer

Sale

日期

Jan 22

股数

1,687

均价

$1.86

总金额

$3K

View Form 4 on SEC.gov

OConnell Daniel Joseph

CEO · Director

Sale

日期

Jan 21

股数

9,346

均价

$1.81

总金额

$17K

View Form 4 on SEC.gov

⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股

1 / 3

▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —

关于 ABOS 内幕交易

ABOS 内幕交易

Acumen Pharmaceuticals, Inc.（ABOS）内幕交易数据来源于公司内部人（包括Meisner Derek M (Chief Legal Officer & Corp Sec), OConnell Daniel Joseph (CEO · Director), Zuga Matt (CFO & Chief Business Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ABOS内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。

如需查看Acumen Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →

买卖信号逻辑

acquisitionOrDisposition字段：

A = 买入 · D = 卖出（处置）

RSU归属（M-Exempt）不计入情绪判断

Form 4SEC要求内部人在任何交易后2个工作日内提交的申报文件

10b5-1预设交易计划，允许内部人按计划自动卖出

Open Mkt公开市场直接买卖（不含股权奖励和期权行权）

机构持仓 SEC 申报财务报表价格历史预测与评级财报

常见问题

ABOS 内幕交易 · 5个问题

Acumen Pharmaceuticals, Inc.（ABOS）的内部人包括高管和董事，如Meisner Derek M (Chief Legal Officer & Corp Sec), OConnell Daniel Joseph (CEO · Director), Zuga Matt (CFO & Chief Business Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。

ABOS 董事内幕交易ABOS 内部人名单Acumen Pharmaceuticals, Inc. 高管内幕活动

▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026